Annual EBITDA
-$112.63 M
-$41.51 M-58.36%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual EBITDA is -$112.63 million, with the most recent change of -$41.51 million (-58.36%) on December 31, 2023.
- During the last 3 years, EWTX annual EBITDA has fallen by -$95.62 million (-562.23%).
- EWTX annual EBITDA is now -1049.12% below its all-time high of -$9.80 million, reached on December 31, 2019.
Performance
EWTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$39.83 M
-$2.26 M-6.01%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly EBITDA is -$39.83 million, with the most recent change of -$2.26 million (-6.01%) on September 30, 2024.
- Over the past year, EWTX quarterly EBITDA has dropped by -$10.88 million (-37.56%).
- EWTX quarterly EBITDA is now -1141.58% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$144.96 M
-$10.88 M-8.11%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM EBITDA is -$144.96 million, with the most recent change of -$10.88 million (-8.11%) on September 30, 2024.
- Over the past year, EWTX TTM EBITDA has dropped by -$43.68 million (-43.12%).
- EWTX TTM EBITDA is now -4418.70% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EWTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.4% | -37.6% | -43.1% |
| 3 y3 years | -562.2% | -37.6% | -43.1% |
| 5 y5 years | -1049.1% | -37.6% | -43.1% |
EWTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -162.3% | at low | -212.5% | at low | -237.6% | at low |
| 5 y | 5-year | -1049.1% | at low | -1141.6% | at low | -4418.7% | at low |
| alltime | all time | -1049.1% | at low | -1141.6% | at low | -4418.7% | at low |
Edgewise Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$39.83 M(+6.0%) | -$144.96 M(+8.1%) |
| Jun 2024 | - | -$37.57 M(+9.8%) | -$134.09 M(+10.5%) |
| Mar 2024 | - | -$34.23 M(+2.7%) | -$121.39 M(+7.8%) |
| Dec 2023 | -$112.63 M(+58.4%) | -$33.33 M(+15.1%) | -$112.63 M(+11.2%) |
| Sep 2023 | - | -$28.95 M(+16.4%) | -$101.28 M(+12.0%) |
| Jun 2023 | - | -$24.88 M(-2.3%) | -$90.42 M(+10.4%) |
| Mar 2023 | - | -$25.46 M(+15.8%) | -$81.88 M(+15.1%) |
| Dec 2022 | -$71.12 M | -$21.99 M(+21.5%) | -$71.12 M(+14.9%) |
| Sep 2022 | - | -$18.10 M(+10.8%) | -$61.88 M(+9.0%) |
| Jun 2022 | - | -$16.34 M(+11.1%) | -$56.79 M(+11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$14.70 M(+15.3%) | -$50.86 M(+18.4%) |
| Dec 2021 | -$42.94 M(+152.5%) | -$12.74 M(-2.1%) | -$42.94 M(+17.7%) |
| Sep 2021 | - | -$13.01 M(+25.0%) | -$36.49 M(+34.8%) |
| Jun 2021 | - | -$10.41 M(+53.6%) | -$27.07 M(+31.6%) |
| Mar 2021 | - | -$6.78 M(+7.7%) | -$20.58 M(+21.0%) |
| Dec 2020 | -$17.01 M(+73.5%) | -$6.29 M(+75.2%) | -$17.01 M(+58.8%) |
| Sep 2020 | - | -$3.59 M(-8.2%) | -$10.71 M(+50.5%) |
| Jun 2020 | - | -$3.91 M(+21.9%) | -$7.12 M(+121.9%) |
| Mar 2020 | - | -$3.21 M | -$3.21 M |
| Dec 2019 | -$9.80 M | - | - |
FAQ
- What is Edgewise Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual EBITDA year-on-year change?
- What is Edgewise Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly EBITDA year-on-year change?
- What is Edgewise Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM EBITDA year-on-year change?
What is Edgewise Therapeutics annual EBITDA?
The current annual EBITDA of EWTX is -$112.63 M
What is the all time high annual EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual EBITDA is -$9.80 M
What is Edgewise Therapeutics annual EBITDA year-on-year change?
Over the past year, EWTX annual EBITDA has changed by -$41.51 M (-58.36%)
What is Edgewise Therapeutics quarterly EBITDA?
The current quarterly EBITDA of EWTX is -$39.83 M
What is the all time high quarterly EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly EBITDA is -$3.21 M
What is Edgewise Therapeutics quarterly EBITDA year-on-year change?
Over the past year, EWTX quarterly EBITDA has changed by -$10.88 M (-37.56%)
What is Edgewise Therapeutics TTM EBITDA?
The current TTM EBITDA of EWTX is -$144.96 M
What is the all time high TTM EBITDA for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM EBITDA is -$3.21 M
What is Edgewise Therapeutics TTM EBITDA year-on-year change?
Over the past year, EWTX TTM EBITDA has changed by -$43.68 M (-43.12%)